Trial
NCT05646797
A Study of ASP2074 in Adults With Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
—
Condition
Advanced Solid Tumors
Intervention
ASP2074
Why stopped
Company Strategic Reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-20